Clinical Trial Update: Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) [Phase 2]

View source ↗

Summary

Phase 2 registrational trial of nivolumab in classical Hodgkin's lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hodgkin Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-12-11